Drawing for RESVIVAX

USPTO serial 87196169

RESVIVAX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LINDEMYER, ANKHI MUKHERJEA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESVIVAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brendan J. Hughes

Brendan J. Hughes COOLEY LLP1299 PENNSYLVANIA AVENUE, NWSUITE 700WASHINGTON, DC 20004

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; vaccine adjuvantsACTIVE—
042Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 25, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 24, 2019EX5GSOU EXTENSION 5 GRANTED—
Oct 21, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 15, 2019EXT5SOU EXTENSION 5 FILED—
Oct 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 14, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 14, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 24, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 12, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2019EX4GSOU EXTENSION 4 GRANTED—
Apr 10, 2019EXT4SOU EXTENSION 4 FILED—
Apr 10, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2018EX3GSOU EXTENSION 3 GRANTED—
Oct 10, 2018EXT3SOU EXTENSION 3 FILED—
Oct 10, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 18, 2018EX2GSOU EXTENSION 2 GRANTED—
Apr 18, 2018EXT2SOU EXTENSION 2 FILED—
Apr 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 19, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 17, 2017EX1GSOU EXTENSION 1 GRANTED—
Oct 17, 2017EXT1SOU EXTENSION 1 FILED—
Oct 17, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 18, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 18, 2017DOCKASSIGNED TO EXAMINER—
Dec 12, 2016TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Dec 12, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 13, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 11, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance